We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+1.61%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$71.7B
AUM Growth
+$2.34B
Cap. Flow
+$1.49B
Cap. Flow %
2.08%
Top 10 Hldgs %
21.97%
Holding
3,809
New
183
Increased
1,708
Reduced
1,572
Closed
206

Sector Composition

Rank Sector Weight
1 Technology 10.59%
2 Financials 9.51%
3 Healthcare 8.04%
4 Industrials 6.62%
5 Communication Services 5.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TT icon
3301
CALL
Trane Technologies
TT
$105B
$153K ﹤0.01%
51,500
+2,000
+4% +$244K
WFC icon
3302
CALL
Wells Fargo
WFC
$265B
$153K ﹤0.01%
+42,000
New +$1.98M
NHA
3303
DELISTED
Nuveen Municipal 2021 Target Term Fund
NHA
$152K ﹤0.01%
15,560
MUS
3304
DELISTED
BLACKROCK MUNIHOLDINGS QUALITY FUND, INC.
MUS
$152K ﹤0.01%
11,849
+67
+0.6% +$845
EDD
3305
Morgan Stanley Emerging Markets Domestic Debt Fund
EDD
$385M
$151K ﹤0.01%
22,842
-1,062
-4% -$7.22K
GIFI
3306
DELISTED
Gulf Island Fabrication
GIFI
$150K ﹤0.01%
28,065
GRF
3307
Eagle Capital Growth Fund
GRF
$41.7M
$150K ﹤0.01%
18,766
+4,177
+29% +$33.4K
ADAM
3308
Adamas Trust
ADAM
$880M
$150K ﹤0.01%
6,165
-55
-0.9% -$1.35K
AFT
3309
DELISTED
Apollo Senior Floating Rate Fund Inc.
AFT
$149K ﹤0.01%
10,051
-130
-1% -$1.93K
DRH icon
3310
Diamondrock Hospitality Co
DRH
$2.48B
$148K ﹤0.01%
14,461
-1,288
-8% -$12.7K
DCH
3311
Dauch Corp
DCH
$1.58B
$147K ﹤0.01%
17,914
+3,108
+21% +$28.2K
ENX
3312
DELISTED
Eaton Vance New York Municipal Bond Fund
ENX
$146K ﹤0.01%
11,701
+1,401
+14% +$17.1K
PBR.A icon
3313
Petrobras Class A
PBR.A
$106B
$146K ﹤0.01%
11,115
-722
-6% -$9.63K
AROC icon
3314
Archrock
AROC
$5.81B
$145K ﹤0.01%
14,568
+1,385
+11% +$13.8K
JVA icon
3315
Coffee Holding Co
JVA
$19.9M
$145K ﹤0.01%
37,150
SM icon
3316
SM Energy
SM
$7.55B
$144K ﹤0.01%
14,828
-1,934
-12% -$19.7K
BKD icon
3317
Brookdale Senior Living
BKD
$3.27B
$140K ﹤0.01%
18,500
-1,700
-8% -$13.5K
NNBR icon
3318
NN Inc
NNBR
$300M
$140K ﹤0.01%
19,650
-5,500
-22% -$41.3K
ATRS
3319
DELISTED
Antares Pharma, Inc.
ATRS
$140K ﹤0.01%
41,705
+289
+0.7% +$952
TBBK icon
3320
The Bancorp
TBBK
$2.81B
$138K ﹤0.01%
13,904
+963
+7% +$9.15K
SLCA
3321
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$138K ﹤0.01%
14,413
-4,086
-22% -$47.1K
KR icon
3322
CALL
Kroger
KR
$34.6B
$136K ﹤0.01%
+73,200
New +$1.7M
CCXI
3323
DELISTED
ChemoCentryx, Inc.
CCXI
$134K ﹤0.01%
19,767
+4,943
+33% +$37.1K
GTE icon
3324
Gran Tierra Energy
GTE
$317M
$133K ﹤0.01%
10,634
+8,941
+528% +$131K
CNSL
3325
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$132K ﹤0.01%
27,672
-20,677
-43% -$97.6K

Similar funds

Raymond James & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Raymond James & Associates held 3,809 positions worth $71.7B, up 3.4% from $69.4B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Raymond James & Associates's Q3 2019 filing shows 183 new, 1,708 increased, 1,572 reduced and 206 closed positions. Its largest new stake was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M. The largest sale was Microchip Technology, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q3 2019 buy was Change Healthcare Inc. Common Stock: 949,970 shares worth $11.5M.
  • Raymond James & Associates added most to Comcast in Q3 2019, an estimated $203M increase.
  • Raymond James & Associates's biggest Q3 2019 reduction was Microchip Technology, cutting an estimated $155M.
  • Raymond James & Associates fully exited Anadarko Petroleum in Q3 2019, selling an estimated $89.3M.
  • Raymond James & Associates's ten largest holdings make up 22% of its $71.7B portfolio in Q3 2019.
  • Raymond James & Associates opened 183 new positions and closed 206 in Q3 2019.
  • Raymond James & Associates's portfolio value rose 3.4% quarter-over-quarter to $71.7B.

Based on Raymond James & Associates's 13F filing for Q3 2019, filed 7 Nov 2019.